title: A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3.
authors.affiliation: RTI International, Research Triangle Park, Durham, NC, USA.
authors.forename: Stephen W
authors.initials: SW
authors.lastname: Erickson
authors.affiliation: Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
authors.forename: Owen W
authors.initials: OW
authors.lastname: Stephens
authors.affiliation: Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
authors.forename: Shweta S
authors.initials: SS
authors.lastname: Chavan
authors.affiliation: Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
authors.forename: Joshua
authors.initials: J
authors.lastname: Epstein
authors.affiliation: Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
authors.forename: Bart
authors.initials: B
authors.lastname: Barlogie
authors.affiliation: Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
authors.forename: Christoph J
authors.initials: CJ
authors.lastname: Heuck
authors.affiliation: Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Annette.juul.vangsted@regionh.dk.
authors.forename: Annette J
authors.initials: AJ
authors.lastname: Vangsted
mesh_terms: D014644:Genetic Variation; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics*; D009101:Multiple Myeloma / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality; D011379:Prognosis; D012318:RNA Polymerase I; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D047908:Intracellular Signaling Peptides and Proteins; C119975:POLR1G protein, human; D012318:RNA Polymerase I
keywords: genetic variants; myeloma; outcome